Table 6.
Compound Crossb |
Number of flies |
Spots per Fly (Number of Spots) Statistical Diagnosisa |
Mean |
Clone formation |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Type |
Small single spots |
large single spots |
Twin spots |
Total spots |
mwhclones |
mvh clone size class |
per 105 per cell |
cells divisionc |
||
(1-2 cells) |
(>2 cells) |
observed |
control connected |
|||||||
m = 2 | m = 5 | m = 5 | m = 5 | |||||||
NIC treatments + RES [0.0004 mM] | ||||||||||
ST | ||||||||||
EtOH | 1 % | 57 | 0.39 (022) | 0.09 (005) | 0.00 (000) | 0.47 (027) | 27 | 1.81 | 0.95 | |
NIC+RES | 0.4560 | 33 | 0.61 (020) - | 0.06 (002) - | 0.00 (000) - | 0.67 (022) - | 22 | 1.45 | 1.35 | 0.40 |
NIC+RES | 1.9000 | 22 | 0.77 (017) + | 0.27 (006) + | 0.00 (000) - | 1.05 (023) + | 23 | 1.87 | 2.15 | 1.15 |
NIC+RES | 3.8000 | 38 | 0.42 (016) - | 0.05 (002) - | 0.00 (000) - | 0.47 (018) - | 16 | 1.06 | 0.85 | -0.10 |
NIC+RES | 11.4000 | 13 | 0.92 (012) + | 0.38 (005) + | 0.00 (000) - | 1.31 (017) + | 17 | 2.47 | 2.70 | 1.70 |
HB | ||||||||||
EtOH | 1% | 35 | 0.34 (012) - | 0.09 (003) | 0.03 (001) | 0.46 (016) | 16 | 1.94 | 0.95 | |
NIC+RES | 0.4560 | 64 | 0.36 (023) + | 0.11 (007) - | 0.00 (000) - | 0.47 (030) - | 29 | 2.21 | 0.95 | 0.00 |
NIC+RES | 1.9000 | 49 | 0.29 (014) - | 0.08 (004) - | 0.02 (001) - | 0.39 (019) - | 18 | 2.33 | 0.75 | -0.20 |
NIC+RES | 3.8000 | 78 | 0.59 (046) + | 0.05 (004) - | 0.03 (002) - | 0.67 (052) - | 52 | 1.63 | 1.35 | 0.45 |
NIC+RES | 11.4000 | 10 | 0.40 (004) - | 0.00 (000) - | 0.00 (000) - | 0.40 (004) - | 04 | 1.25 | 0.80 | -0.10 |
NIC treatments + RES [0.0110 mM] | ||||||||||
ST | ||||||||||
EtOH | 1 % | 57 | 0.39 (022) | 0.09 (005) | 0.00 (000) | 0.47 (027) | 27 | 1.81 | 0.95 | |
NIC+RES | 0.4560 | 45 | 0.69 (031) + | 0.04 (002) - | 0.07 (004) - | 0.80 (036) + | 36 | 1.86 | 1.65 | 0.65 |
NIC+RES | 1.9000 | 42 | 0.76 (032) + | 0.10 (004) - | 0.12 (005) + | 0.98 (041) + | 41 | 2.02 | 2.00 | 1.05 |
NIC+RES | 3.8000 | 52 | 0.62 (032) - | 0.12 (006) - | 0.04 (002) - | 0.77 (040) + | 40 | 1.77 | 1.60 | 0.60 |
NIC+RES | 11.4000 | 37 | 0.38 (014) - | 0.14 (005) - | 0.05 (002) - | 0.57 (021) - | 20 | 2.30 | 1.10 | 0.15 |
HB∗ | ||||||||||
EtOH | 1 % | 60 | 0.33 (020) - | 0.17 (010) - | 0.00 (000) - | 0.50 (030) - | 28 | 2.00 | 0.95 | |
NIC+RES | 0.4560 | 60 | 0.37 (022) - | 0.10 (006) - | 0.02 (001) - | 0.48 (029) - | 29 | 1.97 | 1.00 | 0.05 |
NIC+RES | 1.9000 | 61 | 0.34 (021) - | 0.10 (006) - | 0.05 (003) - | 0.49 (030) - | 29 | 2.03 | 1.00 | 0.00 |
NIC+RES | 3.8000 | 60 | 0.45 (027) - | 0.22 (013) - | 0.00 (000) - | 0.67 (040) - | 40 | 2.42 | 1.35 | 0.40 |
NIC treatments + RES [0.0110 mM] | ||||||||||
ST | ||||||||||
EtOH | 1 % | 60 | 0.45 (027) - | 0.15 (009) - | 0.05 (003) - | 0.65 (039) - | 38 | 2.34 | 1.30 | |
NIC+RES | 0.0125 | 40 | 0.73 (029) + | 0.00 (000) - | 0.00 (000) - | 0.73 (029) - | 29 | 1.14 | 1.50 | 0.20 |
NIC+RES | 0.0250 | 49 | 0.96 (047) + | 0.27 (013) - | 0.00 (000) - | 1.22 (060) + | 59 | 2.08 | 2.45 | 1.10 |
NIC+RES | 0.0500 | 53 | 0.62 (033) - | 0.04 (002) - | 0.00 (000) - | 0.66 (035) - | 35 | 1.34 | 1.35 | -1.10 |
HB | ||||||||||
EtOH | 1 % | 60 | 0.60 (036) - | 0.08 (005) - | 0.00 (000) - | 0.68 (041) - | 40 | 1.37 | 1.35 | |
NIC+RES | 0.0125 | 67 | 0.54 (036) - | 0.00 (000) - | 0.04 (003) + | 0.58 (039) - | 39 | 1.54 | 1.20 | -0.15 |
NIC+RES | 0.0250 | 59 | 0.68 (040) - | 0.07 (004) - | 0.00 (000) - | 0.75 (044) - | 44 | 1.36 | 1.55 | 0.15 |
NIC+RES | 0.0500 | 57 | 0.63 (036) - | 0.05 (003) - | 0.00 (000) - | 0.68 (039) - | 39 | 1.33 | 1.40 | 0.05 |
Statistical diagnoses according to Frei and Würgler (1988) m: minimal risk multiplication factor for the assessment of negative results. For the final statistical diagnosis of all positive (+) and negative (-) results; the non-parametric Mann-Whitney and Wilcoxon U-test with significance levels α and β = 0.05 was used to exclude false positive or negative diagnoses [Frei and Würgler, 1995]. One side binomial test, significance levels α and β: significant results: + (α ≤ 0.05; no significant results: - (β ≤ 0.05).
ST: standard cross; HB: high bioactivation cross.
Clone frequencies per fly divided by the number of cells examined per fly (48,800) gives an estimate of formation frequencies per cell and per cell division in chronic exposure experiments [Frei and Würgler, 1995].∗In HB cross the NIC [11.4 mM] + RES [0.0110 mM] treatment was lethal.